Jiangsu Cowin Biotech Co., Ltd.SSE: 688426

Announcement on Making Provisions for Asset Impairment for 2025

· Issued by Jiangsu Cowin Biotech Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

The board confirmed that the announcement contains no false statements or misleading information. The company conducted a thorough assessment of its assets and determined the need for impairment provisions based on accounting standards. The total impact of these provisions on the company's consolidated profit for the year is reported.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Jiangsu Cowin Biotech Co., Ltd. on 6ix

Earlier from Jiangsu Cowin Biotech

Later from Jiangsu Cowin Biotech

All Jiangsu Cowin Biotech news releases